GHK-Cu (Copper Peptide)

How GHK Binds Copper

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides2 min readLast reviewed 2026-08-233 cited sources

The short answer

GHK coordinates copper(II) through its N-terminal amine, the adjacent backbone nitrogen and the histidine imidazole. That three-nitrogen arrangement is a well-characterised motif for binding divalent metals, and binding displaces a proton, which is why the complex is 62.54 Da heavier rather than 63.55.

Key facts

Coordinating atoms
N-terminal amine, backbone N, imidazole N
Metal
Copper(II)
Proton displaced
One
Mass change
+62.54 Da
Visible signature
Blue colour
Motif name
ATCUN-type (amino-terminal Cu/Ni binding)

The binding motif

GHK's arrangement (a free N-terminal amine, a histidine at position three, and the backbone nitrogens between them) is an example of the amino-terminal copper and nickel binding motif. The same arrangement appears at the N-terminus of human serum albumin, which is not a coincidence: GHK was isolated from the albumin fraction of plasma, and its copper-binding chemistry is of the same type.

Why three nitrogens

Copper(II) prefers four-coordinate square-planar geometry. Three nitrogen donors from the peptide plus a fourth coordination position gives a stable, well-defined complex. Nitrogen donors bind copper more tightly than oxygen, which is why a histidine-containing motif outcompetes arrangements built from carboxylates.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

The displaced proton

A backbone amide nitrogen normally carries a hydrogen and is a poor metal donor. Deprotonating it turns it into a strong one. Copper binding therefore drives loss of that proton, and the resulting complex is one hydrogen lighter than simple addition would predict. This is the chemistry behind the 62.54 Da mass difference and it is a general feature of this binding motif rather than something peculiar to GHK.

Why affinity matters biologically

The framing of GHK as a copper carrier depends on it binding copper tightly enough to hold it in transit and loosely enough to release it where needed. That balance, high affinity but reversible, is what distinguishes a transport molecule from a chelator that simply sequesters a metal. It is also why the copper is described as delivered rather than removed.

The colour is diagnostic

Copper(II) complexes absorb in the red part of the spectrum and appear blue. The intensity and exact shade depend on the coordination environment, so colour is a real qualitative indicator that copper is bound in the expected geometry rather than merely present in the vial.

Frequently asked questions

Which residues bind the copper?
The N-terminal amine of glycine, the backbone nitrogen between glycine and histidine, and the histidine imidazole nitrogen: a three-nitrogen donor set.
Why does binding displace a proton?
A backbone amide nitrogen must be deprotonated to act as a strong metal donor. That loss is why the complex is 62.54 Da heavier rather than 63.55.
Is GHK's motif unique?
No. It is an ATCUN-type site, the same class found at the N-terminus of human serum albumin, from which GHK was originally isolated.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

  • ▸In vitro fibroblast and keratinocyte gene-expression studies
  • ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
  • ▸Wound-healing scratch assays in cell culture models
  • ▸Antioxidant-mechanism studies (copper redox modulation)
  • ▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

  • ✓Store lyophilised vial at 2–8 °C, protected from light
  • ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
  • ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
  • ✓Aliquot reconstituted solution for freeze/thaw minimisation
  • ✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.